PTC Therapeutics, Inc. Free Cash Flow 2011–2025
PTC Therapeutics, Inc. reported $702.34M of free cash flow for fiscal 2025. That was 715.1% higher than fiscal 2024. Compared with fiscal 2020, the change was +431.4%.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $702.34M | +715.1% |
| FY 2024 | $-114.19M | +38.9% |
| FY 2023 | $-186.86M | +51.9% |
| FY 2022 | $-388.67M | -39.0% |
| FY 2021 | $-279.55M | -31.9% |
| FY 2020 | $-211.91M | -88.5% |
| FY 2019 | $-112.40M | -223.6% |
| FY 2018 | $-34.74M | -163.9% |
| FY 2017 | $-13.16M | +87.5% |
| FY 2016 | $-105.34M | +17.1% |
| FY 2015 | $-127.06M | -105.1% |
| FY 2014 | $-61.94M | -29.7% |
| FY 2013 | $-47.77M | +0.7% |
| FY 2012 | $-48.12M | -129.9% |
| FY 2011 | $-20.93M | — |
Source: PTC Therapeutics, Inc. SEC filings — cash flow statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open PTCT 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
PTC Therapeutics, Inc. reported $702.34M of free cash flow for fiscal 2025. That was 715.1% higher than fiscal 2024. Compared with fiscal 2020, the change was +431.4%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for PTC Therapeutics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freePTC Therapeutics, Inc. — frequently asked questions
What is PTC Therapeutics, Inc.'s free cash flow?
PTC Therapeutics, Inc. (PTCT) reported free cash flow of $702.34M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from PTC Therapeutics, Inc.'s official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.